1,280 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

MLTX

MoonLake Immunotherapeutics
US$38.43-7.2%48.5%US$2.4bUS$73.31PB4.5xE2.9%n/a

TXG

10x Genomics
US$19.64-3.0%-64.0%US$2.4bUS$40.00PS3.8xE63.4%n/a

NTLA

Intellia Therapeutics
US$24.22-3.7%-40.9%US$2.3bUS$70.72PS44.4xE33.4%n/a

CLDX

Celldex Therapeutics
US$35.271.7%-0.6%US$2.3bUS$65.38PS382.8xE11.2%n/a

IOVA

Iovance Biotherapeutics
US$8.01-1.8%-0.7%US$2.2bUS$25.75PS1177.2xE64.5%n/a

APGE

Apogee Therapeutics
US$38.00-7.6%n/aUS$2.2bUS$84.83PB2.8xE-24.5%n/a

DCPH

Deciphera Pharmaceuticals
US$25.590.08%76.5%US$2.2bUS$26.85PS12.7xE50.6%n/a

MYGN

Myriad Genetics
US$24.264.6%6.6%US$2.2bUS$25.09PS2.8xE66.8%n/a

VCEL

Vericel
US$45.006.4%23.4%US$2.2bUS$55.33PE4849.4xE49.4%n/a

GPCR

Structure Therapeutics
US$45.57-5.4%55.4%US$2.1bUS$83.10PB4.9xE-21.9%n/a

JANX

Janux Therapeutics
US$40.96-2.5%227.7%US$2.1bUS$63.13PS291.4xE-16.6%n/a

RXRX

Recursion Pharmaceuticals
US$8.85-4.4%20.2%US$2.1bUS$13.00PS45.5xE-9.4%n/a

CGON

CG Oncology
US$31.43-9.3%n/aUS$2.1bUS$68.20PS3885.9xE18.0%n/a

FTRE

Fortrea Holdings
US$23.15-3.4%-31.4%US$2.1bUS$31.80PB1.3xE61.4%n/a

AMRX

Amneal Pharmaceuticals
US$6.65-3.5%130.9%US$2.1bUS$8.25PE-12.2xE118.9%0%

RCKT

Rocket Pharmaceuticals
US$22.482.8%8.7%US$2.0bUS$50.08PB4.6xE57.3%n/a

AMPH

Amphastar Pharmaceuticals
US$40.45-0.1%-29.2%US$2.0bUS$62.60PE12.8xE16.8%n/a

NVAX

Novavax
US$14.00-2.8%109.0%US$2.0bUS$22.80PS2xE65.6%n/a

VERA

Vera Therapeutics
US$35.89-0.4%107.8%US$2.0bUS$57.20PB5.6xE31.4%n/a

KYMR

Kymera Therapeutics
US$31.99-3.9%39.3%US$2.0bUS$50.80PS24.7xE-4.9%n/a

PTGX

Protagonist Therapeutics
US$32.26-3.4%16.8%US$1.9bUS$43.83PE11.7xE-1.7%n/a

ZLAB

Zai Lab
US$18.57-0.6%-26.6%US$1.8bUS$50.79PS6.3xE65.0%n/a

CPRX

Catalyst Pharmaceuticals
US$15.593.5%18.6%US$1.8bUS$27.29PE28.3xE20.0%n/a

FUSN

Fusion Pharmaceuticals
US$21.550.4%332.7%US$1.8bUS$21.10PS898.6xE0.1%n/a
Page 6 of 54
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.